BBNX vs ROK · rev $100.3M vs P/E 48, rev $8.34B
Beta Bionics, Inc. Common Stock (BBNX) versus Rockwell Automation Inc (ROK) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
BBNX currently screens at market cap $640.8M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Not investment advice. Open the BBNX and ROK stock pages for the full models.
Not investment advice.